•HRES 1142 IH 
Whereas polycystic kidney disease is a progressive, genetic 
disorder of the kidneys that causes damage to the kid-
neys and the cardiovascular, endocrine, hepatic, and gas-
trointestinal organ systems; 
Whereas polycystic kidney disease affects the health and fi-
nances of individuals, and equally affects individuals of 
all ages, races, ethnicities, and sexes; 
Whereas, of the individuals diagnosed with polycystic kidney 
disease, approximately 10 percent have no family history 
of the disease, with the disease developing as a sponta-
neous mutation; 
Whereas there are very few treatments and no cure for poly-
cystic kidney disease, which is 1 of the 4 leading causes 
of kidney failure in the United States; 
Whereas almost 50 percent of individuals with polycystic kid-
ney disease experience kidney failure by age 60; 
Whereas friends, loved ones, spouses, and caregivers of indi-
viduals with polycystic kidney disease can assist with the 
challenges created by polycystic kidney disease, including 
by helping such individuals maintain a healthy lifestyle 
and make regular visits to their health care providers; 
Whereas the severity of the symptoms of polycystic kidney 
disease and limited public awareness of the disease may 
cause individuals to forgo regular visits to their physi-
cians or avoid following the health recommendations of 
their doctors, which experts suggest could help prevent 
further complications should kidney failure occur; 
Whereas individuals who have chronic, life-threatening dis-
eases like polycystic kidney disease may experience de-
pression; 
VerDate Sep 11 2014 
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS
•HRES 1142 IH 
Whereas the PKD Foundation and its more than 35,000 pa-
tient and family advocates around the United States are 
dedicated to— 
(1) conducting research to find treatments and a 
cure for polycystic kidney disease; 
(2) fostering public awareness and understanding of 
polycystic kidney disease; 
(3) educating individuals and their families about 
the disease to improve their treatment and care; and 
(4) providing support, including by sponsoring the 
annual ‘‘Walk for PKD’’, to raise funds for polycystic 
kidney disease research, education, advocacy, and aware-
ness; and 
Whereas, on September 4, 2020, the PKD Foundation 
partnered with sister organizations in Canada, Australia, 
and other countries to increase international awareness of 
polycystic kidney disease: Now, therefore, be it 
Resolved, That the House of Representatives— 
(1) expresses support for the designation of 
‘‘National Polycystic Kidney Disease Awareness 
Day’’; 
(2) supports the goals and ideals of National 
Polycystic Kidney Disease Awareness Day to raise 
public awareness and understanding of polycystic 
kidney disease; 
(3) recognizes the need for additional research 
to find a cure for polycystic kidney disease; and 
(4) encourages all people in the United States 
and interested groups to support National Polycystic 
VerDate Sep 11 2014 
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS
•HRES 1142 IH 
Kidney Awareness Day through appropriate cere-
monies and activities to promote public awareness of 
polycystic kidney disease and to foster an under-
standing of the impact of the disease on individuals 
and their families. 
Æ 
VerDate Sep 11 2014 
23:21 Sep 23, 2020
Jkt 099200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HR1142.IH
HR1142
pamtmann on DSKBC07HB2PROD with BILLS